Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)

NCT02398188 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

793

Enrollment

INDUSTRY

Sponsor class

Conditions

Central Abdominal Bulging

Interventions

DRUG: LIPO-202
DRUG: Placebo

Sponsor

Evofem Inc.

Collaborators

[object Object]